The FDA has allowed the launch of a phase 2 study of MT027, an allogeneic chimeric antigen receptor (CAR) T-cell therapy ...
Community oncologists play an important role in expanding access to clinical trials. Patel discusses the value of offering ...
However, the shift to precision oncology involves therapy based more on molecular profiles and the context of an individual ...
Targeted Therapies in Oncology provides evidence-based news and updates on the most current advances in therapeutics, biomarkers, pathways, biomarkers, molecular profiling, and diagnostic testing with ...
"AI will not replace oncologists; it will help interpret complex data and design more precise, adaptive, personalized cancer ...
"AI will not replace oncologists; it will help interpret complex data and design more precise, adaptive, personalized cancer ...
"AI will not replace oncologists; it will help interpret complex data and design more precise, adaptive, personalized cancer ...
Dr. Jason Mouabbi revisits the patient's Grade 2 hyperglycemia at week 6, when fasting glucose reaches 212 mg/dL.
Adding stereotactic body radiation therapy (SBRT) or surgery directed at every known metastasis to first-line systemic ...
Dr. Jason Mouabbi presents a 59-year-old postmenopausal woman with PIK3CA-mutated HR-positive/HER2-negative advanced breast ...
Dr. Jason Mouabbi returns to the patient case, noting improvement in the patient's osseous lesions and resolution of back ...
Dr. Jason Mouabbi discusses additional adverse events that require attention when managing patients with PIK3CA-mutated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results